Sousa T - Search Results

1

Losartan and atenolol on hypertension induced by adenosine receptor blockade.

Morato M, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. Morato M, et al. Among authors: sousa t. Auton Autacoid Pharmacol. 2003 Apr;23(2):133-40. doi: 10.1046/j.1474-8673.2003.00287.x. Auton Autacoid Pharmacol. 2003. PMID: 14511073

2

Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.

Sousa T, Morato M, Albino-Teixeira A. Sousa T, et al. Eur J Pharmacol. 2002 Apr 19;441(1-2):99-104. doi: 10.1016/s0014-2999(02)01488-7. Eur J Pharmacol. 2002. PMID: 12007926

3

The role of angiotensin II in hypertension due to adenosine receptors blockade.

Morato M, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. Morato M, et al. Among authors: sousa t. Eur J Pharmacol. 2002 Nov 29;455(2-3):135-41. doi: 10.1016/s0014-2999(02)02587-6. Eur J Pharmacol. 2002. PMID: 12445579

4

Hypertension due to blockade of adenosine receptors.

Guimarães S, Morato M, Sousa T, Albino-Teixeira A. Guimarães S, et al. Among authors: sousa t. Pharmacol Toxicol. 2003 Apr;92(4):160-2. doi: 10.1034/j.1600-0773.2003.920404.x. Pharmacol Toxicol. 2003. PMID: 12753417 Review.

5

Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors.

Sousa T, Morato M, Fernandes E, Carvalho F, Albino-Teixeira A. Sousa T, et al. J Enzyme Inhib Med Chem. 2004 Feb;19(1):11-5. doi: 10.1080/14756360310001634910. J Enzyme Inhib Med Chem. 2004. PMID: 15202488 Free article.

6

Scavenging of nitric oxide by an antagonist of adenosine receptors.

Sousa T, Fernandes E, Nunes C, Laranjinha J, Carvalho F, Pinho D, Morato M, Albino-Teixeira A. Sousa T, et al. J Pharm Pharmacol. 2005 Mar;57(3):399-404. doi: 10.1211/0022357055614. J Pharm Pharmacol. 2005. PMID: 15807997

7

Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.

Morato M, Pinho D, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. Morato M, et al. Among authors: sousa t. Eur J Pharmacol. 2006 Feb 15;531(1-3):209-16. doi: 10.1016/j.ejphar.2005.12.009. Epub 2006 Jan 24. Eur J Pharmacol. 2006. PMID: 16438958

8

Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla.

Morato M, Pinho D, Sousa T, Tavares I, Albino-Teixeira A. Morato M, et al. Among authors: sousa t. J Neurosci Res. 2006 Mar;83(4):647-55. doi: 10.1002/jnr.20770. J Neurosci Res. 2006. PMID: 16453312

9

Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats.

Pinho D, Sousa T, Morato M, Tavares I, Albino-Teixeira A. Pinho D, et al. Among authors: sousa t. Brain Res. 2006 Feb 16;1073-1074:374-82. doi: 10.1016/j.brainres.2005.12.098. Epub 2006 Feb 2. Brain Res. 2006. PMID: 16457788

10

Purinergic receptors in the splanchnic circulation.

Morato M, Sousa T, Albino-Teixeira A. Morato M, et al. Among authors: sousa t. Purinergic Signal. 2008 Sep;4(3):267-85. doi: 10.1007/s11302-008-9096-0. Epub 2008 Apr 29. Purinergic Signal. 2008. PMID: 18443747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters